Precision Medicine therapy would do wonders on treatment of Covid-19, HIV, Cancer like diseases
Over the last several years, major advances in genomics–specifically, the way diseases manifest and develop in the body at the genetic level–are improving our ability to target illness at each stage and improve the patient experience. As a result, we’re sometimes better able to predict which treatments could be most effective by taking into account patients’ genetic make-up, environment and lifestyle. Perhaps the best example of this approach is CART-19 (University of Pennsylvania)
PA Hospital lung cancer researcher Dr Arutha Kulasinghe has collaborated with local and overseas researchers to identify a genetic marker called IFI27 in the lung tissue and blood of people with Covid-19 which can be used to identify how severe the virus is likely to be in Covid-19 patients and signal whether they need to be hospitalised or are able to quarantine at home. Sydney-based company SpeeDx are now developing a blood test that could be used by an infected person, early on in their symptoms, as a guide to how bad their infection will be. | https://www.pafoundation.org.au/news/36/covid-19-studies-advanced-thanks-to-cancer-research
Lynn Wood
Mel Raassina
Madeline Cunningham
Unwanted Life
Marcus Gordon
angelap